EMA — authorised 26 July 2017
- Marketing authorisation holder: AbbVie Deutschland GmbH & Co. KG
- Status: approved
🇪🇺 Mavyret in European Union
EMA authorised Mavyret on 26 July 2017
Marketing authorisation
Mavyret in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Mavyret approved in European Union?
Yes. EMA authorised it on 26 July 2017.
Who is the marketing authorisation holder for Mavyret in European Union?
AbbVie Deutschland GmbH & Co. KG holds the EU marketing authorisation.